首頁 > 市場調查報告書 > 醫療設備

電子醫療設備

市場調查報告書

商品編碼

2038946

神經刺激設備市場：按產品類型、技術、應用、最終用戶和地區分類

Neurostimulator Market, By Product Type, By Technology, By Application, By End User, By Geography

出版日期: 2026年04月01日 | 出版商:

Coherent Market Insights | 英文 151 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，神經刺激設備市場規模將達到104億美元，到2033年將達到198億美元。預計從2026年到2033年，該市場將以9.63%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	104億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	9.63%	2033年市場規模預測：	198億美元

全球神經刺激設備市場是醫療設備領域的重要組成部分。該市場以能夠傳遞可控電脈衝以刺激神經活動的先進技術為主導。

神經刺激設備種類繁多，包括脊髓刺激設備、深部腦部刺激器、迷走神經刺激設備和周邊神經刺激設備。這些神經刺激設備用於治療慢性疼痛、癲癇、帕金森氏症、憂鬱症和其他疾病。神經刺激設備分為植入式和體外式兩種。這些設備種類繁多，從簡單的型號到可進行高級編程以實現有效治療的多電極型號，應有盡有。

電池技術、無線技術、封閉回路型技術和生物相容性的改進，使這項技術更加人性化。越來越多的人開始了解這項技術及其應用。由於與傳統治療方法相比，它是一種高效且經濟的解決方案，因此正推動全球神經刺激設備市場高速成長。

市場動態

全球神經刺激設備市場的主要促進因素是神經系統疾病、慢性疼痛綜合症和難治性憂鬱症的日益普遍。這在醫療領域造成了巨大的未滿足需求。此外，人口老化也導致各種神經退化性疾病和運動障礙的盛行率上升，擴大了市場規模。同時，醫療專業人員對神經刺激療法相比藥物治療的臨床療效和成本效益的認知不斷提高，也推動了該市場的成長。

技術變革在市場成長中也扮演重要角色。在這方面，小型化、延長電池壽命、無線連接和封閉回路型刺激等技術的進步，因其對設備改進的貢獻而備受關注。市場面臨的挑戰包括高成本、監管障礙以及保險覆蓋不足。此外，設備可靠性、電池壽命以及感染疾病和導線移位等潛在併發症等技術難題，也對市場構成阻礙。

然而，隨著神經刺激器在精神疾病及其他新興領域的臨床應用不斷拓展，該市場也蘊藏著巨大的成長機會。微創植入技術的進步和非侵入性神經刺激產品的研發，正在擴大神經刺激設備適用的患者族群。新興市場醫療基礎設施的改善和醫療旅遊的發展，也為神經刺激設備市場的擴張提供了機會。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還提供了有關市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略的重要見解。
本研究根據以下參數對全球神經刺激設備市場的主要參與者進行了分析：公司亮點、產品系列、主要特徵、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、型號升級、市場擴張和行銷策略做出明智的決策。
這份全球神經刺激設備市場報告的目標受群眾外包括產業內的各種相關人員，例如投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
透過分析全球神經刺激設備市場中使用的各種策略矩陣，相關人員將能夠更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太地區
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第9章競爭情勢

Medtronic
Abbott Laboratories
Boston Scientific Corporation
LivaNova PLC
Nevro Corp
Integer Holdings Corporation
Synapse Biomedical Inc
NeuroPace Inc
Aleva Neurotherapeutics
Nalu Medical Inc

第10章分析師建議

機會
分析師意見
連貫的機會地圖

第11章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI9411

Neurostimulator Market is estimated to be valued at USD 10.4 Bn in 2026 and is expected to reach USD 19.8 Bn by 2033, growing at a compound annual growth rate (CAGR) of 9.63% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 10.4 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	9.63%	2033 Value Projection:	USD 19.8 Bn

The global neurostimulator market is a significant segment in the field of medical devices. This market is dominated by advanced technologies that can deliver controlled electrical impulses for stimulating neural activities.

The various types of neurostimulators include spinal cord stimulators, deep brain stimulators, vagus nerve stimulators, and peripheral nerve stimulators. These types of neurostimulators are used to treat chronic pain, epilepsy, Parkinson's disease, depression, and other medical problems. These neurostimulators are either implantable or external types of devices. These devices can be simple or advanced multi-electrode types that can deliver advanced programming for effective therapy.

The improvement in battery technology, wireless technology, closed-loop technology, and biocompatibility is making this technology more user-friendly. More and more people are becoming aware of this technology and its uses. This is making the global neurostimulator market grow at a high rate because this is an effective and cost-friendly solution for conventional treatments.

Market Dynamics

The major driver for the global neurostimulator market is the rising prevalence of neurological disorders, chronic pain syndromes, and treatment-resistant depression. This creates a large unmet need in the medical community. In addition, the rising age of the population also contributes to the growing prevalence of various neurodegenerative disorders and movement disorders. This increases the market size. In addition to this, growing awareness among healthcare providers about the clinical efficacy and cost-effectiveness of neurostimulation versus pharmaceutical management is also driving this market.

The technological changes have also played a significant role in the growth of the market. In this context, it has to be mentioned that the technological advances in the form of miniaturization, longer battery life, wireless connectivity, and closed-loop stimulation have helped in the improvement of the devices. The challenges faced by the market are the high cost of devices, regulatory challenges, and the lack of reimbursements. In addition, the technological challenges, including the reliability of the devices, battery life, and the possibility of complications such as infection and lead migration, have also posed challenges to the market.

However, the market also offers significant opportunities for growth in terms of clinical application expansion in areas such as mental health disorders and other emerging areas. In terms of minimally invasive implantation technology advancements and the development of non-invasive neurostimulation products, the market is expanding the scope of patients who can be treated with neurostimulators. Improving healthcare infrastructure in emerging markets and the development of medical tourism are also offering opportunities for the expansion of the neurostimulator market.

Key Features of the Study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global neurostimulator market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Medtronic, Abbott Laboratories, Boston Scientific Corporation, LivaNova PLC, Nevro Corp, Integer Holdings Corporation, Synapse Biomedical Inc, NeuroPace Inc, Aleva Neurotherapeutics, and Nalu Medical Inc
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global neurostimulator market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global neurostimulator market

Market Segmentation

Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Spinal Cord Stimulators
- Deep Brain Stimulators
- Vagus Nerve Stimulators
- Sacral Nerve Stimulators
- Gastric Electrical Stimulators
- Transcutaneous Electrical Nerve Stimulators
Technology Insights (Revenue, USD Bn, 2021 - 2033)
- Implantable Neurostimulators
- External Neurostimulators
Application Insights (Revenue, USD Bn, 2021 - 2033)
- Chronic Pain Management
- Parkinson's Disease
- Epilepsy
- Depression
- Urinary and Fecal Incontinence
- Gastroparesis
End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Specialty Clinics
- Ambulatory Surgical Centers (ASCs)
- Research Institutes
Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- Medtronic
- Abbott Laboratories
- Boston Scientific Corporation
- LivaNova PLC
- Nevro Corp
- Integer Holdings Corporation
- Synapse Biomedical Inc
- NeuroPace Inc
- Aleva Neurotherapeutics
- Nalu Medical Inc

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global Neurostimulator Market, By Product Type
- Global Neurostimulator Market, By Technology
- Global Neurostimulator Market, By Application
- Global Neurostimulator Market, By End User
- Global Neurostimulator Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Market Opportunities
Regulatory Scenario
Key Developments
Industry Trends

4. Global Neurostimulator Market, By Product Type, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Spinal Cord Stimulators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Deep Brain Stimulators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Vagus Nerve Stimulators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Sacral Nerve Stimulators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Gastric Electrical Stimulators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Transcutaneous Electrical Nerve Stimulators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

5. Global Neurostimulator Market, By Technology, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Implantable Neurostimulators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
External Neurostimulators
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

6. Global Neurostimulator Market, By Application, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Chronic Pain Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Parkinson's Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Epilepsy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Depression
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Urinary and Fecal Incontinence
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Gastroparesis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

7. Global Neurostimulator Market, By End User, 2021-2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Ambulatory Surgical Centers (ASCs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Bn)

8. Global Neurostimulator Market, By Region, 2021 - 2033, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2026, 2029 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Technology, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

9. Competitive Landscape

Medtronic
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
LivaNova PLC
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Nevro Corp
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Integer Holdings Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Synapse Biomedical Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
NeuroPace Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Aleva Neurotherapeutics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Nalu Medical Inc
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies